PHCANN International has appointed Mr. Sasho Stefanoski as the new Chief Executive Officer (CEO) of the Group.
PHCANN International is one of the leading European companies in the field of production and distribution of medical cannabis according to EU standards and good manufacturing practices, with its offices in Germany, Poland, Croatia and Macedonia.
Sasho Stefanoski has been part of the successful mission of PHCANN International for more than 6 years. He was part of the management team of NYSK HOLDINGS (a subsidiary of PHCANN International) which created the modern production capacity in Macedonia, and participated in the company’s certification process according to the European Union standards which resulted in obtaining the EU GMP certificate.
Previously, Mr. Stefanoski held managerial positions in several governmental institutions in Macedonia and was the CEO of the Health Insurance Fund.
The Board of Directors of PHCANN International recognized Mr. Sasho Stefanoski’s commitment in the past period and decided to entrust the further development of the company to him, in accordance with his clearly declared commitments to increase the sales segment and reduce the operating costs.
At a time when the world and the global economy are still facing challenges related to rising production and transportation costs, Mr. Stefanoski has started the most significant steps for the further expansion of the company’s sales in EU member states, such as Poland, Germany, Czech Republic but also in global markets such as UK, Brazil and Australia.
PHCANN International’s vision in the upcoming period is making its premium medical cannabis products even more accessible to any group of people who require medical cannabis in order to improve their own health, increasing the awareness regarding the benefits of the therapeutic use of cannabinoids for the treatment of various illnesses.
